An overview of the revised European Medicines Agency guideline on the clinical investigation of medicinal products for the treatment or prevention of type 1 and 2 diabetes.
Practical advice on how to use tirzepatide in the management of type 2 diabetes, according to the clinical profile and therapeutic goals. Learn about adverse events, special warnings, precautions, and more.
Self-reported use of melatonin supplements is not linked to the risk for type 2 diabetes or CVD, but regular use may lessen the risk of CVD associated with long-term night shift work.
SGLT2 inhibitors may reduce the risk for dialysis, heart failure and myocardial infarction in patients with type 2 diabetes and stage 5 chronic kidney disease.
Our tailored content service will keep you up to date…
Receive newsletters curated for the busy specialist by our expert editorial team
EIAS can cause hyperglycemia, hypoglycemia, and ketoacidosis in people with diabetes. This case in an older adult with type 1 diabetes shows how EIAS can be managed in an outpatient setting.
HC-HB is a rare movement disorder that can occur in patients with poorly controlled diabetes and hyperglycemia without ketoacidosis. The mainstay of treatment is prompt correction of hyperglycemia.
Diabetic radiculoplexus neuropathy, or Bruns–Garland syndrome, is a rare form of microvascular complication that more commonly affects the lumbosacral plexus and, very rarely, the cervical plexus.
With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report.
The increasing prevalence of type 2 diabetes mellitus (T2DM) and its microvascular and macrovascular complications necessitate an optimal approach to prevention and management. Medical nutrition therapy serves as the cornerstone of diabetes care …
Diabetes is a chronic disease that affects 537 million adults worldwide, or 1 in 10 people, and it is expected to increase to 643 million by 2030 [ 1 ]. This chronic condition requires continuous effort from the individual to manage their treatment …
Genome-wide association studies (GWAS) have significantly advanced the identification of genetic susceptibility variants associated with complex diseases. As of 2023, approximately 800 variants predisposing individuals to the risk of type 2 …
The role of automated insulin delivery systems in diabetes is expanding. Hybrid closed-loop systems are being used in routine clinical practice for treating people with type 1 diabetes. Encouragingly, real-world data reflects the performance and …
Stay up to date with the rapidly changing CGM landscape. Learn how to implement and integrate CGM into diabetes management to improve patient care and outcomes.
Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.
This program is not available to users in the UK and US.
An independent educational program featuring simulated patient consultations. Make knowledge-based decisions on diagnosis and management of CKD with and without co-morbidities, and learn from experts Kevin Fernando and David Wheeler.
An expert-led symposium exploring the prevention and management of type 2 diabetes through dietary interventions. Highlights include discussion of the recent EASD guidelines, therapeutic diets, food types and processing, plus psychological factors that influence patient success, and the drivers of healthy eating and diabetes control.
Glycemic management through appropriate modifications of nutrition, exercise, and medications is of critical importance in preventing complications associated with type 2 diabetes mellitus [ 1 – 3 ]. Lifestyle modifications, including intensive …
The increasing prevalence of type 2 diabetes mellitus (T2DM) and its microvascular and macrovascular complications necessitate an optimal approach to prevention and management. Medical nutrition therapy serves as the cornerstone of diabetes care …
Diabetes is a metabolic disorder characterised by the inability of pancreatic beta cells to control blood glucose levels. The aetiology of the most common form, type 2 diabetes, is heterogeneous, although population genetic studies have identified …
